TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:TEVA

<< 前へ 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2018/05/09	16 : 02	Dow Jones News	California Counties Jump Into Litigation -- WSJ	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/05/09	05 : 00	Dow Jones News	California Counties Jump Into Opioid Litigation -- Update	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/05/09	04 : 44	Dow Jones News	California Counties Jump Into Opioid Litigation	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/05/05	06 : 31	Dow Jones News	ADRs End Higher; Alibaba Rises	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/05/04	07 : 06	Dow Jones News	ADRs End Mostly Higher; Smith & Nephew Falls	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/05/03	21 : 21	Dow Jones News	Teva Raises Outlook After 1Q Results	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/05/03	20 : 00	Business Wire	Teva Reports First Quarter 2018 Financial Results	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/05/03	16 : 02	Dow Jones News	New Front in Opioid Lawsuits: Rise in Insurance Premiums -- WSJ	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/05/03	02 : 13	Dow Jones News	New Front on Opioid Litigation: Suits Over Rising Premiums	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/05/02	21 : 00	Business Wire	Teva to Present AUSTEDO® (deutetrabenazine) Tablets Data at the American Psychiatric Association 2018 Annual Meeting	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/04/28	04 : 50	Business Wire	Teva Presents New Long-Term Data Demonstrating Efficacy and Safety of COPAXONE® (glatiramer acetate injection) 40 mg/mL	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/04/23	21 : 30	Business Wire	Teva to Report First Quarter 2018 Financial Results on May 3, 2018	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/04/19	20 : 00	Business Wire	Teva and the Procter & Gamble Company Have Agreed to Terminate the PGT Healthcare Partnership	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/04/17	21 : 00	Business Wire	Teva to Present New Data Across Multiple Therapeutic Areas at 70th Annual Meeting of the American Academy of Neurology	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/04/05	15 : 49	Dow Jones News	Indivior Sues Companies for Suboxone Copyright Infringement	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/03/27	03 : 49	Business Wire	Teva Announces the Launch of a Generic Version of Lialda® in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/03/24	02 : 27	Business Wire	Teva Announces the Launch of a Generic Version of ALOXI® in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/03/12	21 : 40	Business Wire	Teva to Present at the Cowen & Company 38th Annual Healthcare Conference	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/03/08	06 : 14	Business Wire	Teva Announces Upsizing and Successful Pricing of $4.5 Billion of Senior Notes	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/02/28	23 : 00	Business Wire	Teva Announces Launch of Offering of Senior Notes	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/02/21	01 : 03	Business Wire	Teva Announces Exclusive Launch of Two Strengths of a Generic Version of Solodyn® in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/02/17	01 : 39	Business Wire	Teva Announces U.S. Launch of QVAR® RediHaler™ (Beclomethasone Dipropionate HFA) Inhalation Aerosol	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/02/12	22 : 00	Business Wire	Teva Announces U.S. Launch of QVAR® RediHaler™ (Beclomethasone Dipropionate HFA) Inhalation Aerosol	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/02/09	23 : 00	Business Wire	Teva Announces Launch of a Generic Version of Syprine® in the United States	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/02/09	17 : 02	Dow Jones News	Teva Sustains $11.6 Billion Loss -- WSJ	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/02/09	04 : 24	Dow Jones News	Teva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook Warning	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/02/08	21 : 00	Business Wire	Teva Reports 2017 Full Year and Fourth Quarter Financial Results	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/02/02	21 : 00	Business Wire	European Medicines Agency (EMA) Accepts Fremanezumab Marketing Authorization Application	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/02/01	22 : 26	Business Wire	Teva Completes Amendment to Credit Facilities	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2018/02/01	21 : 00	Business Wire	Teva Announces Completion of Global Women’s Health Divestiture to CVC Capital Partners	NYSE:TEVA	Teva Pharmaceutical Industries Ltd